Curie Therapeutics is a fully integrated next generation radiopharmaceutical company that brings together experts in ligand discovery, radiochemistry, radiobiology and oncology translational and clinical research in order to build a pipeline across a range of solid tumor types. Our mission at Curie is to discover and develop safe, effective, and highly targeted radiopharmaceuticals.
Location: United States, Massachusetts, Woburn
Employees: 11-50
Total raised: $75M
Investors 2
| Date | Name | Website |
| 05.12.2021 | RA Capital... | racap.com |
| 04.12.2021 | Atlas Vent... | atlasventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.12.2021 | Series A | $75M | - |
Mentions in press and media 5
| Date | Title | Description |
| 02.12.2021 | VC Daily: Curie Therapeutics Grabs $75 Million to Develop Radiopharmaceuticals | Good day. Curie Therapeutics Inc. has raised $75 million in Series A financing to develop radiopharmaceutical treatments for cancer, a sign of the growing interest investors are showing in a field that once took a backseat to other types of... |
| 02.12.2021 | VC Daily: Curie Therapeutics Grabs $75 Million to Develop Radiopharmaceuticals | - |
| 01.12.2021 | The future of the metaverse depends on tech companies avoiding past pitfalls | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. The metaverse is all the rage in tech at the moment. But as companies including Facebook (now Met... |
| 01.12.2021 | Curie Therapeutics Raises $75 Million Financing to Further its Mission of Transforming Cancer Care with Precision Radiopharmaceuticals | CAMBRIDGE, Mass., Dec. 1, 2021 /PRNewswire/ -- Curie Therapeutics Inc. ("Curie"), a biotechnology company incubated by Atlas Ventures, Access Biotechnology and RA Capital Management, today announced a Series A investment of $75 mi... |
| 01.12.2021 | Curie Therapeutics Raises $75M Series A | CAMBRIDGE, MA, Curie Therapeutics, a biotechnology company, announced a Series A investment of $75 million. >> Click here for more funding data on Curie Therapeutics >> To export Curie Therapeutics funding data to PDF and Ex... |